Clover Health Investments (CLOV) Proxy filing summary

Executive summary

• Annual meeting scheduled for June 10, 2026, at 11:00 a.m. Eastern Time, to be held virtually.

• Shareholders are invited to vote on key proposals, including director elections, executive compensation, and auditor ratification.

Voting matters and shareholder proposals

• Election of three directors: Demetrios L. Kouzoukas, Andrew Toy, and Thomas L. Tran, with board recommending a vote for all nominees.

• Advisory vote on executive compensation for named executive officers for 2025.

• Ratification of Ernst & Young LLP as independent registered public accounting firm.

• Board may act on other matters that arise during the meeting or any adjournments.

Board of directors and corporate governance

• Board recommends all director nominees for election at the annual meeting.